Visa barely moved, closing at 370.47, just breaking through the 60-day high; the 9-day, 21-day, and 50-day moving averages are in a complete bullish alignment, with the stock price standing 7.8% above the 50-day MA, and RSI at 65.6, not yet in overbought territory.

Pfizer saw a slight gain, closing at 26.20, also hitting a new 60-day high, standing 5.1% above the 21-day MA and 4.5% above the 50-day MA, with an RSI of 65.9.

Both stocks hit new highs accompanied by RSI hovering around 65-66—sufficient momentum but still room to run, representing a relatively healthy breakout pattern. For Visa, the stop-loss level can be set near the 21-day MA around 360; a break below would indicate a failed breakout; for Pfizer, the corresponding level is around 25. There is no prior resistance overhead, so targets must be judged by momentum exhaustion; once RSI rises above 75, positions should start being reduced.